Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study

Neuromuscular Disorders

Volumn 25, Issue 5, 2015, Pages 375-380

  Li, Wenzhu ^a   Zheng, Yiming ^a   Zhang, Wei ^a   Wang, Zhaoxia ^a   Xiao, Jiangxi ^a   Yuan, Yun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Age; Duchenne muscular dystrophy; Fatty infiltration; Muscle magnetic resonance imaging

Indexed keywords

ADDUCTOR LONGUS MUSCLE; ADDUCTOR MAGNUS MUSCLE; ARTICLE; BICEPS FEMORIS MUSCLE; CHILD; CLINICAL ASSESSMENT; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; FATTY INFILTRATION OF THE THIGH MUSCLE; GLUTEUS MAXIMUS MUSCLE; GRACILIS MUSCLE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; MYOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SARTORIUS MUSCLE; SCHOOL CHILD; SKELETAL MUSCLE; ADIPOSE TISSUE; DISEASE COURSE; PATHOLOGY; SEVERITY OF ILLNESS INDEX; THIGH;

ADIPOSE TISSUE; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; SEVERITY OF ILLNESS INDEX; THIGH;

EID: 84927909704     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2015.01.003     Document Type: Article

References (35)

1. Emery A.E. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991, 1:19-29.
2. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
3. Mah J.K., Korngut L., Dykeman J., et al. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2014, 24:482-491.
4. Kim H.K., Laor T., Horn P.S., et al. T2 mapping in Duchenne muscular dystrophy distribution of disease activity and correlation with clinical assessments. Radiology 2010, 255:899-908.
5. Akima H., Lott D., Senesac C., et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2012, 22:16-25.
6. Strober J.B. Therapeutics in duchenne muscular dystrophy. NeuroRX 2006, 3:225-234.
7. Finanger E.L., Russman B., Forbes S.C., et al. Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 2012, 23:1-10.
8. Fischmann A., Hafner P., Gloor M., et al. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 2013, 260:969-974.
9. Klingler W., Jurkat-Rott K., Lehmann-Horn F., et al. The role of fibrosis in Duchenne muscular dystrophy. Acta Myol 2012, 31:184-195.
10. Mathur S., Lott D.J., Senesac C., et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91:1051-1058.
11. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76:346-353.
12. Li W., Zheng Y., Du J., et al. Muscle magnetic resonance imaging of Duchenne muscular dystrophy. Chin J Neurol 2014, 47:16-20.
13. Scott O.M., Hyde S.A., Goddard C., et al. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982, 5:291-301.
14. Johnson K., Page A., Williams H., et al. The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination. Clin Radiol 2002, 57:502-506.
15. Mercuri E., Cini C., Pichiecchio A., et al. Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 2003, 13:554-558.
16. Mercuri E., Pichiecchio A., Counsell S., et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002, 6:305-307.
17. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007, 25:433-440.
18. Wren T.A., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190:W8-12.
19. Wattjes M.P., Kley R.A., Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010, 20:2447-2460.
20. Gaeta M., Messina S., Mileto A., et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 2012, 41:955-961.
21. Forbes S.C., Walter G.A., Rooney W.D., et al. Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 2013, 269:198-207.
22. Arpan I., Forbes S.C., Lott D.J., et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed 2013, 26:320-328.
23. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging 2009, 30:1130-1138.
24. Willcocks R.J., Arpan I.A., Forbes S.C., et al. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord 2014, 24:393-401.
25. Weber M.A., Nagel A.M., Jurkat-Rott K., et al. Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy. Neurology 2011, 77:2017-2024.
26. Tremblay J.P., Skuk D., Palmieri B., Rothstein D.M. A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy. Mol Ther 2009, 17:1122-1124.
27. Kim H.K., Merrow A.C., Shiraj S., et al. Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 2013, 43:1327-1335.
28. Torriani M., Townsend E., Thomas B.J., et al. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2012, 41:437-445.
29. Lou J., Bi W., Li W., et al. Muscle injury induced by different types of contractions in dystrophic mdx mice. J Muscle Res Cell Motil 2012, 32:411-419.
30. Kharraz Y., Guerra J., Pessina P., et al. Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed Res Int 2014, 965631. Epub 2014 May 4. 10.1155/2014/965631.
31. Biressi S., Rando T.A. Heterogeneity in the muscle satellite cell population. Semin Cell Dev Biol 2010, 21:845-854.
32. Hollingsworth K.G., Garrood P., Eagle M., et al. Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 2013, 48:586-588.
33. Pane M., Mazzone E.S., Sormani M.P., et al. 6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. PLoS ONE 2014, 9:e83400. 10.1371/journal.pone.0083400.
34. Kesari A., Pirra L.N., Bremadesam L., et al. Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule. Hum Mutat 2008, 29:728-737.
35. Deburgrave N., Daoud F., Llense S., et al. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat 2007, 28:183-195.